Determination of Octafluoropropane in Canine Exhaled Gas by GC-MS-MS
YANG Ling，CHEN Zhi-liang，LIU Shi-ting，YANG Li
Author information+
Department of Pharmacy，Nanfang Hospital，Nanfang Medical University，Guangzhou 510515，China
{{custom_zuoZheDiZhi}}
{{custom_authorNodes}}
{{custom_bio.content}}
{{custom_bio.content}}
{{custom_authorNodes}}
Collapse
History+
Received
Published
2006-02-28
2007-05-05
Issue Date
2007-05-05
Abstract
OBJECTIVE To develop a method for the determination of octafluoropropane in canine exhaled gas.To assess the exhaled elimination kinetics of octafluoropropane in anesthetized canines following intravenous administration of octafluoropropane-containing human albumin micropheres.METHODS Octafluoropropane-containing albumin microbubbles at dosages of 0.4,0.8 and 1.2 mL·kg-1 were administered intravenously to anesthetized and ventilated canines.The exhaled air samples were analyzed by gas chromatography-mass spectrum-mass spectrum(GC-MS-MS).The plarmacokinetic parameters were evaluated by WINNOLIN software and noncompartmental analyses.RESULTS The calibration curve of GC-MS-MS was linear within the concentration range of 40.92～16 368 nmol·L-1.In dose of 0.4,0.8 and 1.2 mL·kg-1,cmax were(2.837±0.25),(3.06±0.29) and(13.64±2.99)nmol·L-1 respectively;tmax were(16.67±10.53),(21.66±14.12) and(10±0.00) s,respectively.AUC were(154.19±61.83),(353.77±77.89) and(803.21±335.77) nmol·s·L-1,respectively;MRT were(96.68±1.12),(134.39±38.56) and(91.02±9.27)s,respectively.CONCLUSION The method of GC-MS-MS is accurate ,sensitive,precise and usable for OFP.
YNG Ling;CHEN Zhi-ling;LIU Shi-ting;YNG Li.
Determination of Octafluoropropane in Canine Exhaled Gas by GC-MS-MS [J]. Chinese Pharmaceutical Journal, 2007, 42(09): 689-691
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] HERMAN B，ENINAV S，VERED Z. Feasibility of mitral flow assessment by echo-contrast ultrasound，partⅠ. Determination of the properier of echo-contrast agents[J] .Ultrasound Med Biol，2000，26(5)：787-795.
[2] CLARK L N，DITTRICH H C. Cardiac image using Optison[J] .Am J Cardiol，2000，86(4A)：14-18.
[3] OLSZOWSKA W，HLAWATY M，KOSTKIEWICZ M，et al. Role of contrast echocardiography in the improvement of left ventricular endocardial border visualization[J] . Acta Cardiol，2002，57(1)：60-61.
[4] WONG R F，THOMPSON J T. Prediction of kinetics of disappearance of sulfur hexafluoride and perfluoropropane intrazcular gas bubbles[J] .Ophthalmology，1988，95：609.
[5] ANNE L K，PAIGE M M，PAUL A Z，et al. Tissue distribution of 125I-labeled albumin in rats，and whole blood and exhaled elimination kinetics of octafluoropropane in anesthetized canines following intravenous administration of OPTISON(FS069)[J] .Int J Tox，1999，18：49-63.
[6] CORREAS J M，MEUTER A R，SINGLAS E，et al. Human pharmacokinetics of a perfluorocarbon ultrasound contrasrt agent evaluated with gas chromatography[J] . Ultrasound Med Biol，2001，27(4)：565-570.
[7] HUTTER J C，LUU H M，MEHLHAFF P M，et al.Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent[J] .J Ultrasound Med，1999，18(2)：94.
